item management s discussion and analysis of financial condition and results of operations general the following discussion should be read in conjunction with the financial statements and related notes appearing elsewhere herein 
the company develops  manufactures  markets and sells orthopaedic implant devices and related surgical instrumentation to hospitals and physicians 
sales of hip implant products historically accounted for most of the company s revenues and profits  however  since  sales of knee implant products have accounted for an increasing portion of its revenues and profits 
the company anticipates that sales of knee implant products will continue to account for an increasing portion of its revenues and profits 
furthermore  the company anticipates that overall profit margins in the hip implant market may decline as a result of increasing price competition 
the following table sets forth for the periods indicated information with respect to the number of units of the company s products sold and the dollar amount and percentages of revenues derived from such sales dollars in thousands exactech  inc 
sales summary by product line s year ended december  december  december  hip products units units units cemented       porous coated       bipolar prosthesis revision total hip products       knee products cemented cruciate sparing       cemented posterior stabilized      porous coated     revision  total knee products       instrument sales and rental miscellaneous total    results of operations year ended december  compared to year ended december  net sales increased by  or  to  in the year ended december   from  in the year ended december  domestic sales increased  to  in the year ended december   from  in the year ended december  international sales increased  to  in the year ended december   from  in the year ended december  as a percentage of sales  international sales increased from in the year ended december   to in the year ended december  the increase in net sales resulted primarily from increased unit volume of the company s knee implant products 
sales of knee implant products for the year ended december   increased by on a unit basis and by on a dollar basis from the year ended december   as a result of the continued full scale marketing of the optetrak knee system and the release of the revision knee components 
sales of hip implant products for the year ended december  decreased by on a unit basis and by on a dollar basis from the year ended december  the modest average selling price increases in the hip implant products are the result of sales of the higher priced aura hip system revision components 
hip and knee instrument sales and rentals decreased to  in the year ended december   from  in the year ended december  as international knee instrument sales decreased 
gross profit increased by  or  to  in the year ended december   from  in the year ended december  as a percentage of sales  gross profit increased to in the year ended december   from in the year ended december  the increase was primarily the result of a reduction in the unit costs of the company s knee products as production volumes increased 
total operating expenses increased by  or  to  in the year ended december   from  in the year ended december  operating expenses increased as a percentage of sales in the year ended december   to from in the year ended december  sales and marketing expenses increased by  or  to  in the year ended december   from  in the year ended december  as a percentage of sales  sales and marketing expenses increased to in the year ended december  as compared to in the year ended december  sales and marketing expenses increased as a percentage of sales largely due to enhanced commission programs used to maintain existing and attract new agents 
the company s sales and marketing expenses are largely variable costs based on sales levels  with the largest component being commissions 
general and administrative expenses increased by  or  to  in the year ended december   from  in the year ended december  as a percentage of sales  general and administrative expenses remained relatively constant at in the years ended december  and total general and administrative expenses increased on a dollar basis during the most recent year as compared to the prior year primarily as a result of increased legal expenses associated with ongoing legal proceedings 
see item legal proceedings 
research and development expenses increased by  or  to  in the year ended december  from  in the year ended december   as product development expenses for the revision and modular hip systems increased 
as a percentage of sales  research and development expenses remained relatively constant at in the years ended december  and depreciation and amortization expenses increased to  in the year ended december   from  in the year ended december  depreciation and amortization expenses increased in as a result of the increased investment in hip and knee instrumentation 
during the year ended december    of such instruments were placed in service and capitalized  resulting in the increase in depreciation and amortization expenses 
royalty expenses increased by  or  to  in the year ended december   from  in the year ended december   primarily as a result of growth in sales of knee implant products which incur a higher royalty rate 
in  the company recognized royalty expenses of  in connection with the license agreement with the hospital for special surgery and  in connection with other consulting and license agreements 
as a percentage of sales  royalty expenses were and in the years ended december  and  respectively 
the company s income from operations increased by  or  to  in the year ended december   from  in the year ended december  the increase was primarily attributable to the increase in sales and gross profits  partially offset by the increase in operating expenses 
the company recognized net interest income of  in the year ended december   as compared to  in the year ended december  interest income of  for the year ended december   was offset by  of interest expense as the proceeds of the company s ipo consummated in june were invested in short term commercial paper and government backed securities 
the outstanding principal balance of the company s debt averaged approximately  and  during and  respectively 
the average outstanding balance decreased in because approximately  was outstanding on the irb loan only for a period of a month and a half  whereas  the company averaged approximately  in outstanding debt for the first five months of the weighted average interest rate on such debt was and for and  respectively 
in july  the company purchased a interest in techmed  its italian distributor 
prior to september  the investment in the subsidiary was accounted for using the equity method with the company s share of the subsidiary s net earnings loss included as a separate item in the statement of income 
during september  the company wrote off its investment in the subsidiary and reserved for trade receivables deemed uncollectible 
income before provision for income taxes increased by  or  to  in the year ended december   from  in the year ended december  the provision for income taxes was  in the year ended december   compared to  in the year ended december  all outstanding shares of the company s preferred stock were either converted to common stock or redeemed in the year ended december  as a result  there were no preferred stock dividends for the year ended december   as compared to  in the year ended december  as a result  the company had net income of  in the year ended december   compared to  in the year ended december   a increase 
year ended december  compared to year ended december  net sales increased by  or  to  in the year ended december   from  in the year ended december  domestic sales increased  to  in the year ended december   from  in the year ended december  international sales increased  to  in the year ended december   from  in the year ended december  as a percentage of sales  international sales increased from in the year ended december   to in the year ended december  the increase in net sales resulted primarily from increased unit volume of the company s knee implant products 
sales of knee implant products for the year ended december   increased by on a unit basis and by on a dollar basis from the year ended december   as a result of the continued full scale marketing of the optetrak knee system 
sales of hip implant products for the year ended december  increased by on a unit basis and decreased by on a dollar basis from the year ended december  the average selling price reductions in the hip system are the result of increased unit sales of lower priced products including the mcs screw and the opteon medium demand stem 
specifically  the mcs screw system accounted for units of the  hip units increase in sales while providing only of hip system sales 
hip and knee instrument sales and rentals increased to  in the year ended december   from  in the year ended december  as international knee instrument sales increased 
gross profit increased by  or  to  in the year ended december   from  in the year ended december  as a percentage of sales  gross profit decreased to in the year ended december   from in the year ended december  the decrease was primarily the result of an increased mix of international sales 
international sales are typically at lower gross profit margins 
however  the company does not incur commission expense on such sales 
total operating expenses increased by  or  to  in the year ended december   from  in the year ended december  operating expenses decreased as a percentage of sales in the year ended december   to from in the year ended december  sales and marketing expenses increased by  or  to  in the year ended december   from  in the year ended december  as a percentage of sales  sales and marketing expenses remained relatively constant between the year ended december  and the year ended december  at and  respectively 
the company s sales and marketing expenses are largely variable costs based on sales levels  with the largest component being commissions 
general and administrative expenses increased by  or  to  in the year ended december   from  in the year ended december  as a percentage of sales  general and administrative expenses decreased to in the year ended december   from in the year ended december  total general and administrative expenses increased on a dollar basis during the most recent year as compared to the prior year primarily as a result of additional product liability insurance expense resulting from increased sales and the hiring of additional staff 
research and development expenses increased by  or  to  in the year ended december  from  in the year ended december   as product development expenses for the revision knee and hip systems increased while product development expenses for the primary knee systems decreased 
research and development expenses were and of sales for and  respectively 
depreciation and amortization expenses increased to  in the year ended december   from  in the year ended december  depreciation and amortization expenses increased in the most recent year as a result of the increased investment in hip and knee instrumentation 
during the year ended december    of such instruments were placed in service and capitalized  resulting in the increase in depreciation and amortization expenses 
royalty expenses increased by  to  in the year ended december   from  in the year ended december   primarily as a result of growth in sales of knee implant products which incur a higher royalty rate 
in  the company accrued royalty expenses of  in connection with the license agreement with the hospital for special surgery and  in connection with consulting agreements 
as a percentage of sales  royalty expenses were and in the years ended december  and  respectively 
the company s income from operations increased by  or  to  in the year ended december   from  in the year ended december  the increase was primarily attributable to the increase in sales and gross profits  partially offset by the increase in operating expenses 
the company recognized net interest income of  in the year ended december   as compared to net interest expense of  in the year ended december  interest expense of  for the year ended december   was offset by  of interest income as the proceeds of the company s ipo consummated in june were invested in short term commercial paper and government backed securities 
the outstanding principal balance of the company s debt averaged approximately  and  during and  respectively 
the weighted average interest rate on such debt was and for and  respectively 
in july  the company purchased a interest in techmed  its italian distributor 
the investment has been accounted for by the equity method 
included in other income and expenses for the year ended december   are  the company s equity share in the net loss of techmed and the recognition of sublicense income of  the company entered into a sublicense agreement the sublicense agreement with sdp pursuant to which the company received a  license fee in under the terms of the sublicense agreement  an advance on potential royalties in the amount of  was paid to the company 
the  advance is non refundable to the extent that the sub licensee does not receive fda clearance to market the product 
during  the company was notified by the sublicensee that initial applications for fda clearance to market had been denied 
accordingly  the  was recognized as sublicense income because the  was fully earned by the company 
income before provision for income taxes increased by  or  to  in the year ended december   from  in the year ended december  the provision for income taxes was  in the year ended december   compared to  in the year ended december all outstanding shares of the company s preferred stock were either converted to common stock or redeemed in the year ended december  as a result  preferred stock dividends for the year ended december   decreased to  from  in the year ended december  as a result  the company had net income of  in the year ended december   compared to  in the year ended december   a increase 
liquidity and capital resources since inception  the company financed its operations through borrowings  the sale of equity securities and cash flow from operations 
at december   the company had working capital of  compared to  at december  as a result of operating  investing and financing activities  cash and cash equivalents at december  increased to  from  at december  the increase in working capital is primarily the result of the proceeds from an industrial revenue bond financing discussed below  the proceeds of which are being used to finance the company s new facility 
as of december   the company had expended  in costs associated with the construction of the facility 
the company is committed to approximately  in remaining construction costs associated with the completion of the new facility as of december  the company maintains a  credit facility with merrill lynch business financial services  inc which is secured by accounts receivable and inventory and expires in july at december   there was no amount outstanding under the line of credit 
the company believes that funds from operations  the remaining proceeds of the ipo and borrowings under its existing credit facilities will be sufficient to satisfy its contemplated cash requirements for the following twelve months 
operating activities operating activities used net cash of  in the year ended december  as compared to providing net cash of  in the year ended december  the primary reason for the change was the larger increase in inventory during of  as compared to the  increase in inventory that occurred during another factor resulting in more cash being used in operating activities for the year ended december   was the growth in trade receivables 
cash required as a result of the increase in trade receivables was  during  as compared to  during financing activities in november  the company entered into a  industrial revenue bond financing with the city of gainesville  florida the city  pursuant to which the city issued its industrial revenue bonds and loaned the proceeds to the company 
the bonds are secured by an irrevocable letter of credit issued by a bank 
the  credit facility requires the payment by the company of principal installments as follows  per year from through   per year from through  and  per year from through monthly interest payments are based on an adjustable rate as determined by the bonds remarketing agent based on market rate fluctuations as of december  
the proceeds of the credit facility are being used to finance construction of the new facility 
the company s obligations to the bank issuing the letter of credit are secured by the land and improvements comprising the facility 
net cash provided by financing activities decreased from  during the year ended december   to  in the year ended december  net cash provided by financing activities for the year ended december  reflects the proceeds of from the  industrial revenue bond financing with the city while net cash provided by financing activities for the year ended december  reflects the net proceeds of  from the company s ipo consummated in june in  the company also paid  of debt issuance costs associated with the industrial revenue bond financing which will be recognized as expense over the term of the loan 
investing activities the company invested the remaining proceeds of the industrial revenue bond financing and the ipo in short term investments and government backed securities 
as of december    was invested in commercial paper and discount notes yielding approximately and  was invested in merrill lynch s treasury fund and money market fund comprised of commercial paper and government backed securities yielding a return of approximately 
during the year ended december   net cash used in investing activities decreased to  as compared to  in the year ended december  this decrease was primarily due to the maturity of  of short term investments in and reduced purchases of short term investments of  in as compared to  in recent accounting pronouncements see note of notes to financial statements for information concerning recent accounting pronouncements 
cautionary statement relating to forward looking statements the foregoing management s discussion and analysis contains various forward looking statements within the meaning of section a of the securities act of and section e of the securities exchange act of which represent the company s expectations or beliefs concerning future events  including  but not limited to  statements regarding growth in sales of the company s products  profit margins and the sufficiency of the company s cash flow for its future liquidity and capital resource needs 
these forward looking statements are further qualified by important factors that could cause actual results to differ materially from those in the forward looking statements 
these factors include  without limitation  the effect of competitive pricing  the company s dependence on the ability of its third party manufacturers to produce components on a basis which is cost effective to the company  market acceptance of the company s products and the effects of governmental regulation 
results actually achieved may differ materially from expected results included in these statements as a result of these or other factors 

